Legend Biotech
Stock Forecast, Prediction & Price Target
Legend Biotech Financial Estimates
Legend Biotech Revenue Estimates
Legend Biotech EBITDA Estimates
Legend Biotech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $89.79M N/A | $117.00M 30.30% | $285.14M 143.70% | Avg: $1.02B Low: $874.76M High: $1.29B avg. 260.13% | Avg: $1.56B Low: $1.28B High: $2.02B avg. 52.03% | Avg: $2.14B Low: $1.77B High: $2.79B avg. 37.69% | Avg: $2.70B Low: $2.23B High: $3.52B avg. 25.98% |
Net Income
% change YoY
| $-386.20M N/A | $-446.34M -15.57% | $-518.25M -16.10% | Avg: $-153.46M Low: $-269.40M High: $105.64M avg. 70.38% | Avg: $153.65M Low: $-110.93M High: $389.14M avg. 200.12% | Avg: $238.71M Low: $183.94M High: $331.84M avg. 55.35% | Avg: $419.31M Low: $323.11M High: $582.92M avg. 75.65% |
EBITDA
% change YoY
| $-379.10M N/A | $-437.43M -15.38% | $-477.87M -9.24% | Avg: $-1.02B Low: $-1.29B High: $-874.76M avg. -114.88% | Avg: $-1.56B Low: $-2.02B High: $-1.28B avg. -52.03% | Avg: $-2.14B Low: $-2.79B High: $-1.77B avg. -37.69% | Avg: $-2.70B Low: $-3.52B High: $-2.23B avg. -25.98% |
EPS
% change YoY
| -$2.74 N/A | -$2.81 -2.55% | -$2.94 -4.62% | Avg: -$0.56 Low: -$1.53 High: $0.6 avg. 81.06% | Avg: $0.31 Low: -$0.63 High: $2.21 avg. 155.55% | Avg: $1.36 Low: $1.04 High: $1.88 avg. 338.31% | Avg: $2.38 Low: $1.83 High: $3.31 avg. 75.65% |
Operating Expenses
% change YoY
| $462.82M N/A | $509.69M 10.12% | $140.92M -72.35% | Avg: $1.09B Low: $929.25M High: $1.37B avg. 674.04% | Avg: $1.65B Low: $1.36B High: $2.15B avg. 52.03% | Avg: $2.28B Low: $1.88B High: $2.96B avg. 37.69% | Avg: $2.87B Low: $2.36B High: $3.74B avg. 25.98% |
FAQ
What is Legend Biotech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 100.38% in 2025-2028.
We have gathered data from 12 analysts. Their low estimate is -269.40M, average is -153.46M and high is 105.64M.
What is Legend Biotech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 93.96% in 2025-2028.
We have gathered data from 15 analysts. Their low revenue estimate is $874.76M, average is $1.02B and high is $1.29B.
What is Legend Biotech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 162.64% in 2025-2028.
We have gathered data from 12 analysts. Their low earnings per share estimate is -$1.53, average is -$0.56 and high is $0.6.
What is the best performing analyst?
In the last twelve months analysts have been covering Legend Biotech stock. The most successful analyst is James Shin.